دورية أكاديمية

Progenitor recruitment and adipogenic lipolysis contribute to the anabolic actions of parathyroid hormone on the skeleton.

التفاصيل البيبلوغرافية
العنوان: Progenitor recruitment and adipogenic lipolysis contribute to the anabolic actions of parathyroid hormone on the skeleton.
المؤلفون: Maridas DE; Maine Medical Center Research Institute, Scarborough, Maine, USA.; Harvard School of Dental Medicine, Boston, Massachusetts, USA; and., Rendina-Ruedy E; Maine Medical Center Research Institute, Scarborough, Maine, USA., Helderman RC; Maine Medical Center Research Institute, Scarborough, Maine, USA., DeMambro VE; Maine Medical Center Research Institute, Scarborough, Maine, USA., Brooks D; Center for Advanced Orthopaedic Studies, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Guntur AR; Maine Medical Center Research Institute, Scarborough, Maine, USA., Lanske B; Harvard School of Dental Medicine, Boston, Massachusetts, USA; and., Bouxsein ML; Center for Advanced Orthopaedic Studies, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Rosen CJ; Maine Medical Center Research Institute, Scarborough, Maine, USA.
المصدر: FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2019 Feb; Vol. 33 (2), pp. 2885-2898. Date of Electronic Publication: 2018 Oct 24.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural
اللغة: English
بيانات الدورية: Publisher: Federation of American Societies for Experimental Biology Country of Publication: United States NLM ID: 8804484 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-6860 (Electronic) Linking ISSN: 08926638 NLM ISO Abbreviation: FASEB J Subsets: MEDLINE
أسماء مطبوعة: Publication: 2020- : [Bethesda, Md.] : Hoboken, NJ : Federation of American Societies for Experimental Biology ; Wiley
Original Publication: [Bethesda, Md.] : The Federation, [c1987-
مواضيع طبية MeSH: Adipocytes/*cytology , Bone Resorption/*drug therapy , Lipolysis/*drug effects , Mesenchymal Stem Cells/*cytology , Osteoblasts/*cytology , Parathyroid Hormone/*pharmacology , Stem Cells/*cytology, Adipocytes/drug effects ; Adipocytes/metabolism ; Adipogenesis ; Animals ; Bone Resorption/metabolism ; Bone Resorption/pathology ; Caloric Restriction ; Cell Differentiation ; Cells, Cultured ; Female ; Mesenchymal Stem Cells/drug effects ; Mesenchymal Stem Cells/metabolism ; Mice ; Mice, Inbred C57BL ; Osteoblasts/drug effects ; Osteoblasts/metabolism ; Osteogenesis ; Stem Cells/drug effects ; Stem Cells/metabolism
مستخلص: Intermittent administration of parathyroid hormone (PTH) stimulates bone formation in vivo and also suppresses the volume of bone marrow adipose tissue (BMAT). In contrast, a calorie-restricted (CR) diet causes bone loss and induces BMAT in both mice and humans. We used the CR model to test whether PTH would reduce BMAT in mice by both altering cell fate and inducing lipolysis of marrow adipocytes. Eight-week-old mice were placed on a control (Ctrl) diet or CR diet. At 12 wk, CR and Ctrl mice were injected daily with PTH (CR/PTH or Ctrl/PTH) or vehicle for 4 wk. Two other cohorts were CR and simultaneously injected (CR + PTH or CR + Veh) for 4 wk. CR mice had low bone mass and increased BMAT in the proximal tibias. PTH significantly increased bone mass in all cohorts despite calorie restrictions. Adipocyte density and size were markedly increased with restriction of calories. PTH reduced adipocyte numbers in CR + PTH mice, whereas adipocyte size was reduced in CR/PTH-treated mice. In contrast, osteoblast number was increased 3-8-fold with PTH treatment. In vitro, bone marrow stromal cells differentiated into adipocytes and, treated with PTH, exhibited increased production of glycerol and fatty acids. Moreover, in cocultures of bone marrow adipocyte and osteoblast progenitors, PTH stimulated the transfer of fatty acids to osteoblasts. In summary, PTH administration to CR mice increased bone mass by shifting lineage allocation toward osteogenesis and inducing lipolysis of mature marrow adipocytes. The effects of PTH on bone marrow adiposity could enhance its anabolic actions by providing both more cells and more fuel for osteoblasts during bone formation.-Maridas, D. E., Rendina-Ruedy, E., Helderman, R. C., DeMambro, V. E., Brooks, D., Guntur, A. R., Lanske, B., Bouxsein, M. L., Rosen, C. J. Progenitor recruitment and adipogenic lipolysis contribute to the anabolic actions of parathyroid hormone on the skeleton.
References: Bone. 2014 Sep;66:199-204. (PMID: 24953711)
Exp Gerontol. 2009 Sep;44(9):613-8. (PMID: 19501151)
Nutr Res. 2014 Aug;34(8):707-13. (PMID: 25172380)
J Clin Endocrinol Metab. 2014 Apr;99(4):1322-9. (PMID: 24456286)
J Bone Miner Res. 2015 Nov;30(11):1959-68. (PMID: 25990470)
J Bone Miner Res. 2010 Sep;25(9):2078-88. (PMID: 20229598)
Cell Metab. 2017 Mar 7;25(3):661-672. (PMID: 28162969)
Biogerontology. 2001;2(3):165-71. (PMID: 11708718)
J Endocrinol. 2014 Jun;221(3):R163-76. (PMID: 24898127)
J Clin Pathol. 2002 Sep;55(9):693-8. (PMID: 12195001)
Endocrinology. 2015 Nov;156(11):4129-40. (PMID: 26230658)
Cell Signal. 2016 Mar;28(3):204-213. (PMID: 26724218)
Bone. 2014 Sep;66:39-45. (PMID: 24882734)
Endocrinology. 2005 Apr;146(4):1983-90. (PMID: 15618351)
J Bone Miner Res. 2001 Oct;16(10):1846-53. (PMID: 11585349)
Diabetes. 2011 Jan;60(1):17-23. (PMID: 21193735)
Eur J Biochem. 1974 Jul 1;46(1):201-7. (PMID: 4368369)
J Vis Exp. 2018 Jan 6;(131):. (PMID: 29364278)
Br J Clin Psychol. 2001 Jun;40(2):189-95. (PMID: 11446240)
J Bone Miner Res. 2012 Oct;27(10):2075-84. (PMID: 22623172)
J Cell Biochem. 2007 Dec 15;102(6):1504-18. (PMID: 17520664)
Diabetes. 2010 Jul;59(7):1657-66. (PMID: 20413511)
Bone. 2006 Dec;39(6):1361-72. (PMID: 16904389)
Metabolism. 1976 Mar;25(3):251-60. (PMID: 175239)
J Bone Miner Res. 2016 Apr;31(4):852-63. (PMID: 26572927)
PLoS One. 2013 Sep 18;8(9):e74255. (PMID: 24058535)
J Bone Miner Res. 2015 Feb;30(2):309-17. (PMID: 25196529)
Endocrinology. 2014 Aug;155(8):2797-809. (PMID: 24877630)
Cell Metab. 2014 Aug 5;20(2):368-375. (PMID: 24998914)
J Clin Endocrinol Metab. 2013 Mar;98(3):935-45. (PMID: 23393168)
Biochem Soc Trans. 2003 Dec;31(Pt 6):1120-4. (PMID: 14641008)
Int J Obes (Lond). 2006 Sep;30(9):1322-31. (PMID: 16801931)
Endocrinology. 2008 May;149(5):2051-61. (PMID: 18276763)
J Bone Miner Res. 2010 Jul;25(7):1468-86. (PMID: 20533309)
Curr Opin Pharmacol. 2015 Jun;22:41-50. (PMID: 25854704)
J Clin Endocrinol Metab. 2009 Jun;94(6):2129-36. (PMID: 19318450)
J Clin Invest. 2017 Sep 1;127(9):3327-3338. (PMID: 28758904)
J Clin Endocrinol Metab. 2013 Jun;98(6):2294-300. (PMID: 23553860)
Physiol Genomics. 2007 Jan 17;28(2):232-8. (PMID: 16985007)
J Bone Miner Res. 2012 Sep;27(9):1864-71. (PMID: 22508185)
Nat Commun. 2017 Feb 22;8:14745. (PMID: 28224982)
Bone. 2013 Mar;53(1):145-53. (PMID: 23246792)
Curr Opin Psychiatry. 2006 Jul;19(4):389-94. (PMID: 16721169)
Endocrinology. 2013 Aug;154(8):2687-701. (PMID: 23696565)
معلومات مُعتمدة: P30 GM106391 United States GM NIGMS NIH HHS; R24 DK092759 United States DK NIDDK NIH HHS; R01 DK112374 United States DK NIDDK NIH HHS; R56 DK112374 United States DK NIDDK NIH HHS; U54 GM115516 United States GM NIGMS NIH HHS; P20 GM121301 United States GM NIGMS NIH HHS; K01 AR072123 United States AR NIAMS NIH HHS
فهرسة مساهمة: Keywords: PTH; adipocytes; bone; fat; marrow
المشرفين على المادة: 0 (Parathyroid Hormone)
تواريخ الأحداث: Date Created: 20181026 Date Completed: 20190930 Latest Revision: 20240922
رمز التحديث: 20240922
مُعرف محوري في PubMed: PMC6338651
DOI: 10.1096/fj.201800948RR
PMID: 30354669
قاعدة البيانات: MEDLINE
الوصف
تدمد:1530-6860
DOI:10.1096/fj.201800948RR